Earlier studies largely focused on larger peptide-based GLP-1s, such as semaglutide, which were shown to suppress hunger by targeting appetite-regulating networks in the hypothalamus and hindbrain
Moreover, biochemical analyses were performed on whole brain homogenates, assessing malondialdehyde, glutathione and catalase as oxidative stress markers using standard ELISA and spectrophotometric assays
The studys emphasis on temporary effects is crucial, highlighting that results require ongoing maintenance
Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these peptides are approved for compounding
Konopleva M, Zhao S, Hu W, Jiang S, Snell V, Weidner D, Jackson CE, Zhang X, Champlin R, Estey E, Reed JC, Andreeff M
Lean ME, et al